The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis
Abstract
Objective: Standard therapy for antineutrophil cytoplasmic antibody–associated systemic vasculitis (AASV) with cyclophosphamide (CYC) and prednisolone is limited by toxicity. This unblinded, prospective, randomized, controlled trial was undertaken to determine whether methotrexate (MTX) could replace CYC in the early treatment of AASV. Methods: Patients with newly diagnosed AASV, with serum creatinine levels <150 μmoles/liter, and without critical organ manifestations of disease were randomized to receive either standard oral CYC, 2 mg/kg/day or oral MTX, 20–25 mg/week; both groups received the same prednisolone regimen. All drug treatments were gradually tapered and withdrawn by 12 months. Followup continued to 18 months. The primary end point was the remission rate at 6 months (noninferiority testing). Results: One hundred patients were recruited from 26 European centers; 51 patients were randomized to the MTX group and 49 to the CYC group. At 6 months, the remission rate in patients treated with MTX (89.8%) was not inferior to that in patients treated with CYC (93.5%) (P = 0.041). In the MTX group, remission was delayed among patients with more extensive disease (P = 0.04) or pulmonary involvement (P = 0.03). Relapse rates at 18 months were 69.5% in the MTX group and 46.5% in the CYC group; the median time from remission to relapse was 13 months and 15 months, respectively (P = 0.023, log rank test). Two patients from each group died. Adverse events (mean 0.87 episodes/patient) included leukopenia, which was less frequent in the MTX versus the CYC group (P = 0.012), and liver dysfunction, which was more frequent in the MTX group (P = 0.036). Conclusion: MTX can replace CYC for initial treatment of early AASV. The MTX regimen used in the present study was less effective for induction of remission in patients with extensive disease and pulmonary involvement and was associated with more relapses than the CYC regimen after termination of treatment. The high relapse rates in both treatment arms support the practice of continuation of immunosuppressive treatment beyond 12 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Self-citationWegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
FAUCI, A. S., HAYNES, B. F., KATZ, P., & WOLFF, S. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-76 · Cited by 2,001
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Self-citationJennette, J. C., & Falk, R. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372106 · Cited by 1,323
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Self-citationSavige, J., Gillis, D., Benson, E., Davies, D., Esnault, V., Falk, R. J., Chris Hagen, E., Jayne, D., Charles Jennette, J., Paspaliaris, B., et al. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.4.507 · Cited by 884
Self-citationHagen, E. C., Daha, M. R., Hermans, J., Andrassy, K., Csernok, E., Gaskin, G., Lesavre, P., Lüdemann, J., Rasmussen, N., Sinico, R. A., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00807.x · Cited by 740
Self-citationReinhold-Keller, E., Beuge, N., Latza, U., De Groot, K., Rudert, H., Nölle, B., Heller, M., & Gross, W. L. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1021::aid-anr10>3.0.co;2-j · Cited by 696
Self-citationExley, A. R., Bacon, P. A., Luqmani, R. A., Kitas, G. D., Gordon, C., Savage, C. O. S., & Adu, D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400222 · Cited by 619
Self-citationHogan, S. L., Nachman, P. H., Wilkman, A. S., Jennette, J. C., & Falk, R. J. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7123 · Cited by 386
Westman, K. W., Bygren, P. G., Olsson, H., Ranstam, J., & Wieslander, J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95842 · Cited by 318
An analysis of forty‐two wegener's granulomatosis patients treated with methotrexate and prednisone
Sneller, M. C., Hoffman, G. S., Talar‐Williams, C., Kerr, G. S., Hallahan, C. W., & Fauci, A. S. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380505 · Cited by 265
Savage, C., Harper, L., & Adu, D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80118-3 · Cited by 231
Langford, C. A., Talar‐Williams, C., Barron, K. S., & Sneller, M. C. (1999) · Arthritis & Rheumatism · Cited by 210
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe
Watts, R. A., Gonzalez-Gay, M. A., Lane, S. E., Garcia-Porrua, C., Bentham, G., & Scott, D. G. I. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.2.170 · Cited by 205
de Groot, K., Reinhold‐Keller, E., Tatsis, E., Paulsen, J., Heller, M., Nölle, B., & Gross, W. L. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391215 · Cited by 185
Self-citation(1992) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068681 · Cited by 183
Development and validation of a disease extent index for Wegener's granulomatosis.
de Groot, K., Gross, W. L., Herlyn, K., & Reinhold‐Keller, E. (2001) · PubMed · Cited by 166
Self-citationReinhold‐Keller, E., Fink, C. O. E., Herlyn, K., et al. (2002) · Arthritis Care & Research · doi:10.1002/art.10459 · Cited by 129
Rasmussen, N., Jayne, D. R. W., Abramowicz, D., Andrássy, K., BACON, P. A., Tervaert, J.-W. C., Dadonlené, J., Feighery, C., van Es, L. A., Ferrario, F., et al. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06161.x · Cited by 111
Self-citationAphasia, Apraxia, and Agnosia in the Diagnosis of Dementia
Kramer, J. H., & Duffy, J. M. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106848 · Cited by 70
Wluka, A. E., Buchbinder, R., Mylvaganam, A., Hall, S., Harkness, A., Lewis, D., Littlejohn, G. O., Miller, M. H., & Ryan, P. F. J. (2000) · PubMed · Cited by 57
Cited by
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
EULAR recommendations for the management of primary small and medium vessel vasculitis
Mukhtyar, C., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C. G. M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088096 · Cited by 990
Self-citationde Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Self-citationLong-term patient survival in ANCA-associated vasculitis
Flossmann, O., Berden, A., de Groot, K., Hagen, C., Harper, L., Heijl, C., Höglund, P., Jayne, D., Luqmani, R., Mahr, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137778 · Cited by 939
Self-citationMahr, A. D., Jover, J. A., Spiera, R. F., Hernández‐García, C., Fernández‐Gutiérrez, B., LaValley, M. P., & Merkel, P. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22754 · Cited by 622
Metadata
- Authors
- De Groot, K., Rasmussen, N., Bacon, P. A., Tervaert, J. W. C., Feighery, C., Gregorini, G., Gross, W. L., Luqmani, R., & Jayne, D. R. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-07-28
- Volume
- 52
- Issue
- 8
- Pages
- 2461-2469
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2126960177
- Cited by
- 801
- References
- 25
- FWCI
- 29.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.